根据GMP指南对于包装材料的定义(见以下内容),包装材料不包括发运用的外包装材料,如果捆扎带和膜是发运用的,非药品常规包装,是不需按物料包装材料管理。至于是否限制供应商,根据公司内部程序定义。另外物料及供应商是否管控,应基于风险评估,一般来讲,内包材对产品质量保证是有贡献的,首先不应和产品发生反应,不应吸附产品和污染产品,而第二层甚至外层材通常是来保护产品运输过程中包装不被损坏的,也可能还对产品质量提供额外的质量保证,甚至或有负面效应(外包材的成分不明,可能对产品质量有影响)。比如二级包装的塑料膜目的是为了在运输时防止盒标签的信息反复磨损而模糊不清(三期不明劣药),且膜的厚度会影响封膜效果,因此按外包材供应商方式管理。
【中国GMP】包装材料(Packaging Materials):药品包装所用的材料,包括与药品直接接触的包装材料和容器、印刷包装材料,但不包括发运用的外包装材料。[1]
【中国药典】药包材:即直接与药品接触的包装材料和容器,系指药品生产企业生产的药品和医疗机构配制的制剂所使用的直接与药品接触的包装材料和容器。[2]
【FDA cGMP】Containers and Closures: Interpreted as the primary packaging of a finished drug product. May include glass, plastic or metal containers, bottles, vials, ampules, screw caps, lids, stoppers, seals, desiccants, fillers, etc.(Not defined in the CGMP regulations) [3]
【EU GMP Part I】Packaging materials: Any material employed in the packaging of a medicinal product, excluding any outer packaging used for transportation or shipment. Packaging materials are referred to as primary or secondary according to whether or not they are intended to be in direct contact with the product. [4]
【EU GMP Part II & ICH Q7A】Packaging Material: Any material intended to protect an intermediate or API during storage and transport. [5][6]
【WHO GMP】Packaging material: Any material, including printed material, employed in the packaging of a pharmaceutical, but excluding any outer packaging used for transportation or shipment. Packaging materials are referred to as primary or secondary according to whether or not they are intended to be in direct contact with the product. [7]
这{{threadTextType}}正{{isAdminText}}
为帮助审核人员更快处理,请填写举报原因:
为帮助审核人员更快处理,请填写举报原因: